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Human K-casein was prepared from whole casein by successive hydroxyapatite and thiol-Sepharose chroma- 
tographies. The primary structure of its 99-residue N-terminal fragment has been determined by sequencing 
peptides obtained by tryptic and chymotryptic digestions of the whole protein. This fragment overlaps the 
known sequence of the 65-residue C-terminal fragment. The 158-residue sequence of human K-casein was 
compared to those of goat, ewe, cow and rat K-caseins. Only 22% of the residues are identical in homologous 
positions, The rate of divergence of the 93-residue N-terminal segment (para-K-casein) appears to be higher 
than that of the rest of the molecule. 
x-Casein Primary struclure 
1. INTRODUCTION 
In cow milk a large proportion of the proteins 
occurs as a suspension of micelles containing 4 dif- 
ferent casein species (asIr 12~2, P x), water and 
minerals. Chymosin (EC 3.4.23.4) and pepsin trig- 
ger milk coagulation in the stomach of suckling 
calves by splitting x-casein (169 residues) into 2 
parts: para-x-casein, the 105-residue N-terminal 
fragment, and caseinomacropeptide (CMP), the C- 
terminal end [I]. 
Mature human milk contains micelles [2] but fl- 
casein is by far the major human casein. Its amino 
acid sequence has been published [3]. Some ancient 
data suggested the occurrence of a x-casein in 
human milk. A definite proof of its existence was 
obtained in our group by Chobert et al. in 1976 [4] 
when they isolated a human CMP, determined 
almost completely its amino acid sequence and 
observed clear homologies with CMPs of different 
species, including cow [5]. The sequence was com- 
pleted later by Fiat et al. [6]. Nevertheless, 
numerous attempts at isolating human x-casein 
failed until Yamauchi et al. in 1981 [7] succeeded 
in obtaining a homogeneous preparation. Their 
* To whom correspondence should be addressed 
Protein evolution Human 
results will be discussed with ours. This report 
presents the method we have used for preparing 
human x-casein and the amino acid sequence of 
para-x-casein, thus giving the complete primary 
structure of the protein. 
2. MATERIALS AND METHODS 
2.1. Preparation of human x-casein 
Pooled mature milk was used for preparing 
whole human casein by acid precipitation. This ca- 
sein was chromatographed on hydroxyapatite 
(Biogel HTP, Biorad, Richmond, CA), as in [8] 
with the following modifications: 2 mM K- 
phosphate, 100 mM KCI, 6.6 M urea, pH 5.9, in- 
stead of 5, 205, 4.5 and 6.9, respectively. The first 
fraction, which contained x-casein, was dialyzed, 
freeze-dried and chromatographed on thiol- 
Sepharose 4B (Pharmacia, Uppsala) as in [9]. The 
fraction which was retained and eluted with cys- 
teine was pure x-casein. For sequence determina- 
tion 2.5 mg x-casein were reduced and alkylated 
with iodoacetate. 
2.2. Gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) was performed as in [lo] on 15% 
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acrylamide gels. Isoelectric focusing (IEF) was per- 
formed as in [I 11. 
2.3. Amino acid analysis 
Samples (1 nmol) of alkylated x-casein were 
hydrolyzed with 5.7 N HCI in evacuated and 
seaied tubes for 24,48 and 96 h at 110°C. For pep- 
tides (1-2 nmol), hydrolysis times were 24 h and, 
when necessary, 96 h. Analyses were performed 
with an IX5000 amino acid analyzer (Biotronik, 
Munich). The program used separated 
glucosamine and galactosamine from the other 
amino acids. For the determination of these amino 
sugars, alkylated x-casein was hydrolyzed with 4 N 
WC1 at 100°C for 6 h. The eventual occurrence of 
tryptophan was assessed on cellulose thin layer us- 
ing Ehrlich’s reagent [12]. Carboxypeptidase A 
(CPA) and carboxypeptidase I3 (CPB) digests were 
analyzed as such after va~u~rn drying. 
2.4. Enzymic digestions 
x-Casein was digested with chymosin (Sigma, 
St. Louis, MO) at 30°C in 50 mM Na citrate buf- 
fer, pH 6.2 (E/S = 1: 10000, molar ratio) for 
various time periods. Trypsin and ~hymotrypsin 
(Sigma, TPCK- and TLCK-treated respectively) 
were employed for digesting x-casein and some 
peptides, in 0.1 M ammonium bicarbonate, pH 
8.0, at 4O”C, with E/S = 1: 50 and 1: 100, diges- 
tion times 4 and 5 h, respectively. A few peptides 
were digested either with proline-specific endopep- 
tidase (Seikagaku, Kogyo, Tokyo) in 0.2 M N- 
ethylmorpholine acetate, pH 7.0, at 30°C for 4 h 
(&“S = 1:20), or with S. aureus V8 protease 
(Sigma) in 50 mM ammonium acetate, pH 4.0, at 
37°C for 16 h (E/S = 1: 30). x-Casein and its N- 
terminal chymotr~tic peptide were treated with 
pyroglutamate aminopeptidase (Boehringer, 
Mannheim, FRG) according to Podell and 
Abraham [ 131. Digestions of peptides with CPA or 
CPB (Worthington, Freehold, NJ; PMSF treated) 
were carried out in 0.1 M ammonium bicarbonate, 
pH 8.0, at 37°C for various time periods (E/S = 
1: 50). When acidic residues occurred near the C- 
terminus, CPA was used in 0.1 M pyridine acetate 
buffer, pH 5.4. 
2.5, Fraetianat~on o~~eptide mixtures 
AI1 separations were achieved by reverse-phase 
HPLC. The equipment consisted of a 720 System 
Controller, two 6000 A pumps, 1 U6K injector, 
1 pm Bondapak Cl8 column (Waters, Mifford, 
MA) and a CE 2023 variable wavelength UV 
monitor (Cecil, Cambridge, England). Most frac- 
tionations were carried out using the following sol- 
vent system I: A, 0.115% trifluoroacetic acid 
(TFA); B, 0.1% TFA in 60% CH3CN. Some 
purifications were achieved with system II: A, 
25 mM ammonium acetate, pH 6.0; B, 40070 
50 mM ammonium acetate, pH 6.0, 60% CH&N. 
AI1 separations were carried out at 40°C with 
linear gradients, at a flow rate of 1 ml/min. The 
absorbance was recorded at 220 nm. The manually 
collected fractions were dried under vacuum. 
2.6. Edman degradation 
The manual ‘partitioning method for small pep- 
tides’ described by Tarr 1141 was used. For the 
identification of PTH amino acids the procedure 
of Bhown et al. [IS] was employed with the follow- 
ing modifications: column Cl8 Novapak (Waters, 
1B; 
u 
2 3 
Fig. I. Isoelectric focusing (A) and SDS-polyacrylamide 
gel e~ectrophores~s (B) of human x-casein before and 
after chymosin action. (Al) Chymosin-treated x-casein 
(60 min reaction); (A2, Bl) x-casein, (B2, B3, B4) 
chymosin-treated x-casein (IS, 30, 60 min reaction), 
(B5) human whole casein, overloaded for a clear 
observation of x-casein and whey protein contaminants. 
(a) ~-Lactalbumin, (b) lysozyme and para-x-casein, (c) 
degradation products of @casein, (d) @casein, (e) x- 
casein, (f) heavy chains of sIgAs, (g) lactoferrin. 
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Milford, MA); 30°C; no acetone in solvent A; 
1 ml/min; linear gradient from A/B (85 : IS) to 
A/B (25 : 75) in 14 min, followed by a 1 min linear 
gradient to the initial conditions and 9 min 
equilibration in the starting mixture. The absor- 
bance was recorded at 269 nm with 0.05 AUFS full 
scale. PTH dehydrothreonine was successively 
recorded at 269 and 312 nm. 
terminal tryptic and chymotryptic peptides, the 
procedure described by Muranova et al. [16] was 
used on the N-terminal chymotryptic peptide. This 
peptide was treated with 17% methyIamine at 
37°C for 14 h, dried and subjected to Edman 
degradation. 
3. RESULTS AND DISCUSSION 
2.7. ~de~tif~~ution of the amino-terminus of the 3. I. Preparation and amino acid composition of 
N-terminal chymotryptic peptide human x-casein 
As treatments with pyroglutamate aminopep- Fig.1 shows the electrophoretic patterns ob- 
tidase had failed on the intact protein, the N- tained by SDS-PAGE and IEF with our prepara- 
Table 1 
Amino acid composition of human x-casein 
Amino acid This work This worka From Bovine x-casein 
(from amino (from sequence) Yamauchi from Mercier 
acid analysis) et aI. [71b et ai. (191 
SCM-Cys 
Asp 
Asn 1 
Thr 
Ser 
c&l 
Gin I 
Pro 
GfY 
Ala 
Val 
Met 
Be 
Leu 
Tyr 
Phe 
His 
Trp 
Lys 
Arg 
0.8 0.8 2 
12.0 12.8 
18.0’ 
8.0’ 
18 
1 
17.8 
7.5 
; 11 
1 
14 
13 
15.4 ; 1s 
1 
15.2 
28.1 28 
1.9 1 
13.5 14 
11.1 13 
0.4 1 
12.0 13 
3.5 3 
11.3 12 
3.1 3 
4.0 4 
d d _ _ 
5.0 5 
7.1 8 
;: 27 
1 
28.7 20 
2.6 2 
13.8 15 
12.4 11 
1.3 2 
10.6 13 
4.3 8 
10.3 9 
3.1 4 
3.0 3 
1.1 1 
4.9 9 
7.7 5 
Total 158 169 
Mr (peptide 
chain) 17707 19023 
GICN 
GalN 
21.6 
11.7 
a Including the amino acid composition of CMP, according to Chobert et al. [4] 
b Recalculated for 158 residues 
’ Values obtained by extrapolation to 0 h 
d No reaction with Ehrlich’s reagent 
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6 
7 A-B 
TIME (min.) 10 30 40 
Fig.2. Separation of tryptic peptides of human SCM-x-casein by HPLC. Elution with system I. Conditions in section 2. 
tion of human x-casein. The location of the cor- 
responding fraction in whole human casein is also 
shown in SDS-PAGE. The protein displays at least 
11 bands in IEF. These arise from 
microheterogeneity of the carbohydrate moieties, 
since they disappear after chymosin treatment 
which only leaves 2 para-x-derivatives. Indeed it is 
known that these carbohydrates are all attached to 
CMP [7], which is not stained by Coomassie blue. 
SDS-PAGE gives an apparent M, of -14000 for 
the major para-x-derivative. The reason for the 
appearance of the minor one is not known. 
The amino acid and hexosamine composition is 
shown on table 1. The assumption was first made 
that the protein had the same number of amino 
acid residues as its bovine counterpart. Thereafter 
calculations were made from the actual number of 
residues deduced from the sequence. The absence 
- 
Fig.3. Separation of chymotryptic peptides of human 
SCM-x-casein by HPLC. Elution with system I. See 
conditions in section 2. 
-7 7 
8 A-B 
I /I / 
TIME h”, 20 30 LO 50 60 
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t T3P2 & 
I. 
T3P3 
L--- T? 
IO 
Glu-Gln-Lys-Pro-Ala-Cys-His-Glu-Asn-Asp-Glu-A~g-Pro-Phe-Tyr-Gln-Lys-Thr-Ala-Pro-Tyr-Val-Pro-Met-Tyr-Tyr-Val-Pro-Asn-Ser- 
d&7 C6C-GI 
C6C .I. 
_ _ ++: CK-G2 
717-7-ir 
-71-7-7 
SC2 Ia TeC4-+ 
J 4‘7 - - - - \- ,- 
T7A Tee ---m-77 ‘p7~777fv.w 
Tyr-pro-Tyr-Tyr-Gly-Thr_Asn-Leu-Tyr_Gln-A~g-Arg-Pr~-Ala-Ile-Ala-Ile-Asn-Asn-Pro-Tyr-Val-P~o-A~g-Thr-Tyr-Ty~-Ala-ASn-p~O- 
aT5 & T4 
-7-Y- 70 ~--F77777-80 c-+-77 -7 997 
Ala-Val-Val-Arg-Pro-His-Ala-Gln-Ile-Pro-Gl~-A~g-Gl~-Tyr-Leu-P~o-Asn-S~r-His-Pro-Pro-Th~-Val-Val-A~g~Arg-P~o-Asn-Leu-Hi~- 
-c5 I- c4 \!& C6D & c7- 
777cj---/ --T-/--z- --17 , C8A .L -c9 -- 
7--r-7 y-17 ~77v7-jrI 
k. T7BC! 
7 r-p--r777 
100 I IO 120 
~-Ser-Phe-Ile-Ala-Ile-Pro-Pro-Lys-L~-Ile-Gln-Asp-Lys-Ile-Ile-Ile-Pro-Thr-Ile-Asn-Thr-Ile-Ala-Thr-Val-Cl~-P~~-Th~-P~~- 
130 140 I50 
Ala-pro-Ala-Thr-Gl~-Pro-Thr-Val-Asn-Ser-Val-Val-Thr-P~o-Glu-Ala-Phe-Thr-~lu-Ser-lle-lle-Th~-Ser-Th~-P~~-Gl~-Th~-p~~-Th~- 
158 
Val-Ala-Val-Pro-Thr-Thr-Sex-Ala 
Fig.4. Alignment of the peptides used for sequence determination. The vertical arrow indicates the chymosin-sensitive 
bond. (T) Tryptic peptides, (C) chymotryptic peptides, (P) peptides obtained by using proline-specific endopeptidase, 
(G) peptides obtained by using S. aureus V8 protease. Sequence of CMP (94-158) from [4]; exact assignment of residues 
143, 144, 153-157 from [6]. Amino acids released by: (-) Edman degradation, (-) carboxypeptidases. 
of tryptophan was deduced from the negative reac- 
tion obtained with Ehrlich’s reagent on the whole 
protein and its tryptic fragments. The Edman 
degradation on the intact molecule did not release 
any PTH-amino acid. 
3.2. Amino acid sequence of tryptic peptides 
The HPLC elution profile of the SCM-x-casein 
tryptic digest is shown in fig.2. From the amino 
acid sequence of the human CMP [4] it could be in- 
ferred that the tryptic hydrolysate of the whole 
protein should contain 2 peptides originating from 
the CMP: a pentapeptide and the 54-residue C- 
terminal peptide which should contain all the car- 
bohydrates. Furthermore the junction peptide 
overlapping para-x-casein and 6 residues of CMP 
should also be present. The 54-residue C-terminal 
peptide was found as a spreading zone (fraction 
T2, fig.2) which was identified by amino acid 
analyses of the fractions located between peaks 3 
52 
and 4, 4 and 5. Three fractions, Tl, T6, T8, cor- 
responded to pure peptides. Fractions T3, T4, T5, 
all contaminated by T2, were purified by HPLC. 
Likewise fraction 7 was resolved into 2 pure pep- 
tides, T7A and T7B. Tl and T2 were not studied 
any further since they obviously corresponded to 
the 2 expected peptides from CMP. T3, from 
which no PTH amino acid could be obtained, was 
treated with proline-specific endopeptidase. Five 
peptides (T3Pl-T3P5) were obtained from the 
digest by HPLC. Chymotryptic digests of T7B and 
T8 were resolved by HPLC into 2 and 5 peptides, 
respectively. The results of Edman degradations 
on all tryptic peptides are shown in fig.4. T3P2 did 
not give any PTH derivative. 
3.3. Amino acid sequence of chymotryptic 
pep tides 
From a chymotryptic digest of SCM-x-casein, 
12 main peptide fractions were obtained by HPLC 
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Fig.5. Alignment of the sequences of goat [5], ewe [22], 
cow variant A [ 191, human and rat [ 181 x-casein. 
Standard one-letteq symbols for amino acids; (0) 
identical residue; ( ) chymosin/pepsin-sensitive bond; 
phosphates are atta E hed to S 161 in goat, ewe and cow, 
S 179 in goat and ewe. In the pre-proteins, the N- 
terminal amino acid of ewe [20] and cow [21] x-caseins 
is Q. For the ewe protein, E and Q have been placed in 
position 2 and 7, respectively, as determined on the pre- 
protein 1201. For the cow protein, N occurs at position 
89 I211 instead of E (191. The assignment of residues 143, 
144, 153-157 in the human protein has been taken from 
[6]. The N-terminal sequence of the goat protein, Z-Z-Z- 
N-Z-Z-Z- [5] is considered to be identical with those of 
the ewe and cow proteins. 
(fig.3). Fractions Cl-CS, C7, C9-Cl1 each con- 
tained a single peptide. The large trailing peak Cl2 
contained all the carbohydrates. It was a mixture 
of 3-4 large peptides starting at Leu-75 or Phe-93 
and ending at Phe-137 or at the carboxyl terminus 
(fig.4). Refractionation of fractions C6 and Cg by 
HPLC gave peptides C6A-C6D and C8A-CK. 
Fraction Cl2 was not studied any further. Peptide 
C6C, which did not react with PITC, was digested 
with S. aureus V8 protease. The digest was re- 
solved by HPLC into 2 peptides, C6C-Cl and 
C6C-G2. The former did not react with PITC. 
Peptide C6C was treated with methylamine [16] to 
unblock a putative pyroglutamyl residue and con- 
vert it into iVs-methylglutamine. Two steps of Ed- 
man degradation were carried out on the treated 
peptide and the synthetic peptide Pyr-Glu-Ala 
which had been similarly treated. The same pat- 
terns were obtained by HPLC with the PTH 
derivatives at the first step. PTH-Gln was detected 
in second position with C6C. The results of Edman 
degradation on all chymotryptic peptides are 
shown on table 2. 
The sequence data obtained from the tryptic and 
chymotryptic peptides (fig.4) give the complete se- 
quence of human para-x-casein without ambigu- 
ity. Taking into account peptide T7B, which 
overlaps para-x-casein and CMP, they give the se- 
quence of the whole human x-casein molecule 
(fig.4), which is compared to those of the other 
known x-caseins in fig.5. The protein is composed 
of 158 residues. From determinations of fucose, 
galactose, glucosamine, galactosamine and sialic 
acid (given in wt%), Yamauchi et al. [7] deduced 
a carbohydrate content of -40% for their x-casein 
preparation. The values we present here for the 
glucosamine and galactosamine contents of our 
preparation (table 1) have been obtained on a 
molar basis by carrying out amino acid composi- 
tion and amino sugar determination on the same 
solution of x-casein. This gave values approx- 
imately twice higher than those reported in [7] but 
in the same ratio. Assuming, as a first approxima- 
tion, that the other carbohydrates occur in our 
preparation in the proportions of the figures given 
in [7], we have recalculated them on the basis of 
our results for the amino sugars. This gives an Mr 
of 19400 for the whole carbohydrate moiety. The 
M, of the peptide chain, deduced from the se- 
quence, being 17707, this leads to a value of 
-37 100 for the M, of the whole x-casein, a value 
close to that of 38000 recently found by ultracen- 
trifugation by Azuma et al. [17]. Human x-casein 
53 
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Fig.6 Percent differences between para-x-caseins 
(below diagonal) and CMPs (above diagonal) from goat, 
ewe, cow, human and rat. All positions where a residue 
occurred in one or both sequences were considered. 
could then contain -52% carbohydrates. 
It was postulated earlier that CMP could have 
evolved at a much faster rate than para-x-casein. 
This assumption was based on a comparison be- 
tween the rates of evolution of CMPs from cow, 
water buffalo, goat, ewe, pig and human on the 
one hand, and those of para-x-caseins of 3 closely 
related species (bovine, goat, sheep) on the other 
[5]. Fig.6 compares percent differences of CMPs 
and para-x-caseins from cow, goat, ewe, human 
and rat. The rat x-casein sequence was recently 
deduced from that of the corresponding cDNA 
[18]. It shows that the rate of evolution of para-x- 
casein is higher than that of CMP. This is mainly 
due to the high homology which can be observed 
in fig.5 between residues 112 and 134 (55 and 22% 
identity in the 5 species for this fragment and the 
whole molecule, respectively). This region contains 
bond 113-l 14 whose cleavage by pepsin or 
chymosin leads to milk coagulation in the 
stomach. It thus appears that, during evolution, x- 
casein retained only the minimal features that seem 
necessary for its role, which also include a high 
proportion and even distribution of proline 
residues, a high hydrophobicity and positive net 
charge of para-x-casein and a negative net charge 
of CMP. 
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